The World Health Organization, WHO, Monday approved a wider roll out of a second malaria vaccine that was developed by Britain’s Oxford University and the Serum Institute of India. The vaccine is already in use in Ghana and Burkina Faso with expectations of a quick roll out across Africa in the coming months. For more, reporter Henry Ridgewell produced this report.